PEAR THERAPEUTICS INC (PEAR)

US7047231052 - Common Stock

0.0292  -0.02 (-38.91%)

After market: 0.0287 0 (-1.71%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-75.49M-65.14M-2.18K
Depreciation Amortization
3.97M2.25MN/A
Change In Working Capital
-9.76M-5.95M1.65K
Interest Paid
3.56M3.71MN/A
Other non cash items
-32.61M-40.21MN/A
OPERATING CASH FLOW
-113.89M-109.04M-530.00
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-3.47M-4.63MN/A
Other Investing Activity
-5.99M7.51MN/A
INVESTING CASH FLOW
-9.46M2.88MN/A
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/A45.53K
Stock Issued/Repurchased
2.15M20.78MN/A
Other Financing Activity
0.00143.30M-45.00K
FINANCING CASH FLOW
2.15M164.08M530.00
 
CHANGE IN CASH
-121.20M57.92M0.00
 
FREE CASH FLOW
Operating Cash Flow
-113.89M-109.04M-530.00
Capital Expenditure
-3.47M-4.63MN/A
FREE CASH FLOW
-117.36M-113.67M-530.00

All data in USD

Charts